Finalist
The Jazz Age: New rhythms with AI
by Camino
Summary of work
Jazz Pharmaceuticals embodied innovation in the pharmaceutical industry by integrating generative AI into its operations to address strategic challenges with previously unseen efficiency. Facing the launch of a major competitor in the haemato-oncology space, Jazz, foresaw AI as a solution. They successfully piloted two projects—a Veeva-approved branded reprint carrier and a medical competitor landscape analysis— to demonstrate that AI use is not only cost-effective, achieving significant savings (60% and 22% of the traditional costs, respectively), but also time-efficient and offering added value and insights. By pioneering AI use in pharma, Jazz has showcased its commitment to innovation and set a baseline for new industry benchmarks with AI. The success of these initiatives not only spurred the expansion of AI-driven projects within the company, but also positions Jazz as a leader in AI adoption in pharma.
Judges’ comments
The Jazz Age is a great example of the work in this category and it was fantastic to see it presented in person. The early adoption was very interesting and impressed that it got them further than many others in this field. The judges were fascinated seeing the selection process and where they said no. The pragmatism learnt along the way is remarkable.
